This site is intended for healthcare professionals only
LoginRegister
AstraZeneca Faces NPPA Heat Over Symbicort Pricing, Slapped Rs 60 Crore Showcause NoticeAstraZeneca Estimates Rs 35 Crore Tax Benefit After ITAT Remands Transfer Pricing Issues
Pulse Pharma Gets CDSCO Panel Nod to Manufacture, Market Aripiprazole Oral SolutionSix Pharma Suppliers Blacklisted in Five Years for Failing Quality Standards: MoS Anupriya Patel
novavax to sell facility in BohumilNovavax to sell Bohumil manufacturing facility to Novo Nordisk for USD 200 million
Alembic Pharma bags USFDA tentative approval for Olopatadine Hydrochloride Ophthalmic Solution to treat itchy eyesAlembic Pharma bags USFDA tentative approval for Olopatadine Hydrochloride Ophthalmic Solution to...
FDA Grants Breakthrough Therapy Designation to Sacituzumab TirumotecanUSFDA grants Breakthrough Therapy Designation to Sacituzumab Tirumotecan for Metastatic Nonsquamous...
Cough syrup racket: Rs 38 crore assets of wanted accused under scannerAssam police dispose of 37000 bottles of contraband phensedyl cough syrup
JnJ completes acquisition of Halda Therapeutics, its novel platform for cancer treatmentIntas Pharma to acquire Udenyca business from Coherus BioSciences
Gland Pharma profit rises 12 percent to Rs 184 crore in Q2Gland Pharma Vice President (Strategy, Investments & Investor Relations) Ankit Gupta tenders...
Cipla Names Arun Kakatkar as Global Chief People OfficerPromoters Samina, Rumana Hamied exit Cipla by selling 1.72 percent stake
CDSCO Panel Accepts Glenmarks Apremilast Trial Report, Seeks 2-Year PSUR DataGlenmark's Win: NPPA revises price of Telmisartan, Cilnidipine FDC after data review
USFDA Approves Bionpharmas Generic HIV Drug EtravirineUSFDA nod to Gland Pharma Latanoprost Ophthalmic Solution
Novartis Loses India Patent on Heart Failure Drug VymadaNovartis bolsters Neuroscience pipeline with in-licensing of PTC518 for Huntington's disease
X